May I please seek your views on how you see the impact of CSL entering in renal with the new acquisition? Given the fact that CSL PE multiples are now approaching or almost around 40, will you be buying it at this stage? Given the hike in interest rates are going to continue, there is a good chance that CSL may approach further bargaining territory.
- Forums
- ASX - By Stock
- CSL
- Ann: Trading Halt
Ann: Trading Halt, page-249
Featured News
Add CSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$294.49 |
Change
-0.510(0.17%) |
Mkt cap ! $142.6B |
Open | High | Low | Value | Volume |
$295.01 | $296.50 | $293.51 | $60.50M | 205.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 17 | $294.47 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$294.51 | 13 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 72 | 294.520 |
5 | 38 | 294.510 |
2 | 26 | 294.500 |
2 | 17 | 294.480 |
3 | 67 | 294.470 |
Price($) | Vol. | No. |
---|---|---|
294.560 | 44 | 5 |
294.570 | 19 | 4 |
294.590 | 11 | 2 |
294.600 | 25 | 3 |
294.610 | 28 | 2 |
Last trade - 15.22pm 10/10/2024 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |
The Watchlist
EL8
ELEVATE URANIUM LTD
Murray Hill, MD & CEO
Murray Hill
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online